AMA has a digital medicine workgroup, and I recall that a year or two ago they recommended against the use of "artificial intelligence" in coding nomenclature, concerned it was too vague.
I think we may see an example of that in the two similar codes for PreciseDx breast cancer slide-based tests, PLA codes 0220U and 0418U. The latter code is for biopsy specimens. The latter, newer code seems to replace "AI" with "AAA" or augmented algorithmic analysis.
Precise Dx Breast Cancer Test
Oncology, breast cancer, image analysis with artificial intelligence assessment of 12 histologic and immunohistochemical features, reported as a recurrence score.
Precise Dx Breast Cancer Biopsy Test
Oncology (breast), augmentative algorithmic analysis of digitized WSI of 8 histologic and immunohistochemical features, reported as a recurrence score